TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

Eva Rettinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.